chr6-41061346-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006789.4(APOBEC2):āc.150C>Gā(p.Asn50Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000471 in 1,529,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006789.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
APOBEC2 | NM_006789.4 | c.150C>G | p.Asn50Lys | missense_variant | 2/3 | ENST00000244669.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
APOBEC2 | ENST00000244669.3 | c.150C>G | p.Asn50Lys | missense_variant | 2/3 | 1 | NM_006789.4 | P1 | |
OARD1 | ENST00000482853.5 | c.145+8730G>C | intron_variant, NMD_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 152132Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000296 AC: 55AN: 185586Hom.: 0 AF XY: 0.000275 AC XY: 27AN XY: 98032
GnomAD4 exome AF: 0.000481 AC: 663AN: 1377154Hom.: 0 Cov.: 31 AF XY: 0.000429 AC XY: 290AN XY: 675902
GnomAD4 genome AF: 0.000374 AC: 57AN: 152250Hom.: 0 Cov.: 31 AF XY: 0.000255 AC XY: 19AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.150C>G (p.N50K) alteration is located in exon 2 (coding exon 2) of the APOBEC2 gene. This alteration results from a C to G substitution at nucleotide position 150, causing the asparagine (N) at amino acid position 50 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at